|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Designing drug regimens for special intensive care unit populations显示文摘This review is intended to help clinicians design drug regimens for special populations of critically ill patients with extremes of body size, habitus and composition that make drug choice or dosing particularly challenging due to the lack of high-level evidence on which to make wellinformed clinical decisions. The data sources included a literature search of MEDLINE and EMBASE with reviews of reference lists of retrieved articles. Abstracts of original research investigations and review papers were reviewed for their relevance to drug choice or dosing in the following special critically ill populations: patients with more severeforms of bodyweight or height, patients with amputations or missing limbs, pregnant patients, and patients undergoing extracorporeal membrane oxygenation or plasma exchange. Relevant papers were retrieved and evaluated, and their associated reference lists were reviewed for citations that may have been missed through the electronic search strategy. Relevant original research investigations and review papers that could be used to formulate general principles for drug choice or dosing in special populations of critically ill patients were extracted. Randomized studies with clinically relevant endpoints were not available for performing quantitative analyses. Critically ill patients with changes in body size, habitus and composition require special consideration when designing medication regimens, but there is a paucity of literature on which to make drug-specific, high-level evidencebased recommendations. Based on the evidence that is available, general recommendations are provided for drug choice or dosing in special critically ill populations. | Brian L Erstad | 2015 | World Journal of Critical Care Medicine2015，4，2： | 3 |
| 2 | Stress ulcer prophylaxis in trauma patients显示文摘 | Barletta JF Erstad BL Fortune JB | | 0，，06： | 1 |
| 3 | The university hospital consortium guidelines for the use of albumin,nonprotein colloid,and crystalloid solutions显示文摘 | VERMEULEN L C JR RATIKO T A ERSTAD B L | 1995 | Arch Intern Med1995，155，4： | 1 |
| 4 | Proton-pump inhibitors for acute peptic ulcer bleeding显示文摘 | Erstad BL | | 0，，： | 1 |
| 5 | Changes in crude oil composition during laboratory biodegradation: Acids and oil-water, oil-hydrate interracial properties 显示文摘 | Erstad K Hvidsten I V Askvik K M Barth T | 2009 | Energ Fuel2009，23，8： | 1 |
| 6 | ASHP therapeutic guidelines on stress ulcer prophylaxis显示文摘 | Erstad BL Grant KL Boucher BA etal | 1999 | Am J Health Syst Pharm1999，56，4： | 1 |
| 7 | Stress ulcer in the post- operative period显示文摘 | Allen ME Kopp B J Erstad BL | 2004 | Am J Heath Syst Pharm2004，61，6： | 1 |
| 8 | Treatment of hypertension in the perioperative patient显示文摘 | Erstad BL Barletta JF | 2000 | Ann Pharmacother2000，34，1： | 1 |
| 9 | A paradigm for consensus-the University Hospital Consortium Guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions显示文摘 | VERMEULEN L C PRATKO T A ERSTAD B L | 1995 | Arch Intern Med1995，155，4： | 1 |
| 10 | Enteral nutrition support in acute pancreatitis显示文摘 | Erstad BL | 2000 | Ann pharmacother2000，34，4： | 1 |
| 11 | Cost implications of and potential ad- verse events prevented by interventions of a critical care pharmacist 显示文摘 | Kopp BJ Mrsan M Erstad BL | 2007 | Am J Health-Syst Pharm2007，64，23： | 1 |
| 12 | Stress ulcer prophylaxis in thepostoperative period显示文摘 | Allen ME Kopp BJ Erstad BL | 2004 | Am J Health Syst Pharm2004，61，6： | 1 |
| 13 | Enteral support in acute Pancreatitis显示文摘 | Erstad BL | 2000 | Ann Pharmatother2000，34，： | 1 |
| 14 | Analyzing computer based patient records: a review of literature显示文摘 | Erstad TL | 2003 | J Healthcare Inf Manage2003，17，4： | 1 |
| 15 | Stress ulcer prophylaxis in trauma patients显示文摘 | BARLETTA J F ERSTAD B L FORTUNE J B | 2002 | Critical Care2002，6，6： | 1 |
| 16 | Octreotide: A new somatostatin analogue 显示文摘 | Katz MD Erstad BL | 1989 | Clin Pharmacol1989，8，： | 1 |
| 17 | Stress ulcer prophylaxis in the postoperative period 显示文摘 | Allen ME Kopp B J Erstad BL | 2004 | Am J Health - Syst Pharm2004，61，3： | 1 |
| 18 | Systemic hemostafie medications for reducing surgical blood loss显示文摘 | Erstad BL | 2001 | Ann Pharmacother2001，35，： | 1 |
| 19 | Enteralnutrition support in acute pancreatitis显示文摘 | Erstad BL | 2000 | Ann Pharmacother2000，34，： | 1 |
| 20 | Analyzing computer based patient records:a review of literature显示文摘 | Erstad TL | 2003 | J Healthcare Inf Manage2003，4，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员